Trial Profile
A phase 3, open-label, extension study of S-6810 in patients with mycosis fungoides or Sezary syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Interferon gamma-1a (Primary)
- Indications Mycosis fungoides; Sezary syndrome
- Focus Adverse reactions
- Sponsors Shionogi
- 07 Sep 2015 New trial record